Delivery Order SPE2DB20D1100-SPE2DB23FD1N8

Award Date 8/17/23
Potential Completion Date 8/18/23
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $7,751.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561926624 Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a period of performance from August 24, 2023 through August 25, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency leverages contracts such as this to efficiently procure...
The Defense Logistics Agency awarded a $19,316 delivery order to Amerisourcebergen Drug Corporation for 4561806979 Pulmozyme 1 MG/ML Ampul 2.5ML. The firm fixed price order is for delivery of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from August 14 to August 15, 2023. As a top supplier of medical materiel to the Department of Defense, Amerisourcebergen will fulfill this order from the Defense Logistics Agency in support of the...
The Defense Logistics Agency awarded a $7,315.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561401118 Pulmozyme 1 MG/ML Ampul 2.5ML. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from July 3, 2023 through July 5, 2023. The Defense Logistics Agency is a combat support agency under the Department of Defense responsible for worldwide logistics support. This delivery order is likely associated with the...
The Defense Logistics Agency awarded a $14,683.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561948828 Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a period of performance from August 25, 2023 through August 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency leverages contracts such as Federal Supply Schedule 65IIa...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $30,000 to Amerisourcebergen Drug Corporation to supply Pulmozyme 1 mg/ml ampules. The delivery order was issued under an existing Amerisourcebergen contract vehicle and calls for the contractor to deliver 2.5ml ampules of the respiratory drug to a location in Conshohocken, Pennsylvania, with performance to be completed between September 8-11, 2023. Amerisourcebergen Corporation will perform as the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $15,183.21 to Amerisourcebergen Drug Corporation for the provision of 4561998203 Pulmozyme 1 mg/ml ampul 2.5ml. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 30, 2023 through August 31, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports military readiness by...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $21,892.87 to Amerisourcebergen Drug Corporation for the provision of 4561455012 Pulmozyme 1 mg/ml ampul 2.5ml. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is associated with the Defense Logistics Agency's medical supply chain and will provide the specified pharmaceutical products to support Department of Defense...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at four thousand nine hundred nine dollars and forty-eight cents ($4,909.48) to Amerisourcebergen Drug Corporation for the delivery of 4561655438 PULMOZYME 1 MG/ML AMPUL 2.5ML. The place of performance will be Amerisourcebergen's corporate office located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 31, 2023 and ending on August 1, 2023. No set aside designation or...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at eleven thousand five hundred ten dollars and seventy-five cents ($11,510.75) to Amerisourcebergen Drug Corporation for the provision of two point five milliliter (2.5mL) ampules of the drug Pulmozyme at one milligram per milliliter (1mg/mL) concentration. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania through July 20-21, 2023. No major...
The Defense Logistics Agency Troop Support Medical awarded a $9,024.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561969547 units of Pulmozyme 1 mg/ml ampules, 2.5 ml each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 28, 2023 through August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD1N8
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at twenty-three thousand eight hundred eighteen dollars and sixty-one cents ($23,818.61) to Amerisourcebergen Drug Corporation for the provision of 4561851111 Pulmozyme 1 mg/ml ampul 2.5ml. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania from August 17, 2023 through August 18, 2023. The Defense Logistics Agency functions to support the resupply needs of the United States Department of Defense and this order is likely associated with the Agency's pharmaceutical procurement programs. No set aside designation or subcontracting arrangements were indicated.

Generated 12/22/23, 5:24 PM